Amino acids in the vitreous and intravitreal fluid in rhegmatogenous retinal detachment patients with different proliferative vitreoretinopathy grades
DOI:
https://doi.org/10.31288/oftalmolzh201542834Keywords:
rhegmatogenous retinal detachment, proliferative vitreoretinopathy, amino acids, neurotransmitters, intravitreal fluid, vitreousAbstract
Background:Proliferative vitreoretinopathy (PVR) is known to worsen the treatment prognosis of rhegmatogenous retinal detachment (RRD) and to result in irreversible loss of vision due to apoptotic or necrotic process in retinal neurons. Some studies have tried to examine the role of amino acids (first of all, neurotransmitters) in the development of proliferative vitreoretinopathy (PVR). Glutamate is known to cause migration and proliferation of RPE and/or glial cells. Based on this fact, it has been hypothesized that antagonists of glutamate may prevent or reduce the intensity of these processes. Additionally, it has been proved that elevated vitreous glutamate levels in proliferative diabetic retinopathy are potentially toxic to retinal ganglion cells, and that elevated vitreous levels of gamma-aminobutyric acid and glutamate promote the development of vasoproliferative processes. In general, little is still known about the role of immune acids and that of the imbalance in their levels in the pathogenesis of retinal pathology, and the importance of the issue of PVR complications is of no doubt.
Purpose: To investigate the features of the distribution of amino acids in the vitreous and intravitreal fluid in patients with RRD with different PVR grades.
Materials and Methods: Eighty-eight patients (88 eyes) were ofthalmologically examined and underwent surgery for RRD. Gas-liquid chromatography was utilized to determine the levels of 15 amino acids in vitreous and intravitreal fluid samples obtained at the time of vitrectomy and fluid-gas exchange to provide tamponade, respectively. Data were analyzed taking into account the PVR grade (grades A, B and C in 11, 64 and 13 patients, respectively).
Results: In RRD patients, the levels of amino acids under study in the vitreous and, especially, in intravitreal fluid increased significantly with the increase in PVR grade to grade B. If the PVR continued to progress to grade C, a tendency to decrease in the neurotransmitter levels was observed, but they remained statistically significantly higher than those in grade A. Significant correlations were revealed between PVR grade and amino acid levels in intravitreal fluid, and, in most cases, in the vitreous. Further progression of the proliferative process was accompanied by a higher increase in the levels of excitatory amino acids (aspartate and glutamic acid), than that of the inhibitory one (glycine).
Conclusion: The data presented provide evidence for the role of elevated amino acid (first of all, neurotransmitter) levels in the development of proliferative processes in RRD. The imbalance found in the levels of excitatory and inhibitory neurotransmitters (aspartate and glutamic acid vs. glycine) results in the excitotoxic effect, and creates pathochemical preconditions for retinal degeneration.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Г. В. Левицкая

This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) that allows users to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author as long as they cite the source.
COPYRIGHT NOTICE
Authors who publish in this journal agree to the following terms:
- Authors hold copyright immediately after publication of their works and retain publishing rights without any restrictions.
- The copyright commencement date complies the publication date of the issue, where the article is included in.
DEPOSIT POLICY
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) during the editorial process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work with an acknowledgement of its initial publication in this journal.
- Post-print (post-refereeing manuscript version) and publisher's PDF-version self-archiving is allowed.
- Archiving the pre-print (pre-refereeing manuscript version) not allowed.








